Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient socioeconomic status as a prognostic factor for allo-SCT.
Silla L, Fischer GB, Paz A, Daudt LE, Mitto I, Katz B, da Graça Grossini M, Bittencourt HN, Jochims A, Fogliatto L, Bittar CM, Friedrisch JR, Bittencourt RI. Silla L, et al. Among authors: bittencourt hn, bittencourt ri. Bone Marrow Transplant. 2009 Apr;43(7):571-7. doi: 10.1038/bmt.2008.358. Epub 2008 Nov 3. Bone Marrow Transplant. 2009. PMID: 18978820
DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil.
Pezzi A, Moraes L, Valim V, Amorin B, Melchiades G, Oliveira F, da Silva MA, Matte U, Pombo-de-Oliveira MS, Bittencourt R, Daudt L, Silla L. Pezzi A, et al. Adv Hematol. 2012;2012:697691. doi: 10.1155/2012/697691. Epub 2012 Nov 8. Adv Hematol. 2012. PMID: 23193409 Free PMC article.
High prevalence of anemia in children and adult women in an urban population in southern Brazil.
Silla LM, Zelmanowicz A, Mito I, Michalowski M, Hellwing T, Shilling MA, Friedrisch JR, Bittar CM, Albrecht CA, Scapinello E, Conti C, Albrecht MA, Baggio L, Pezzi A, Amorin B, Valim V, Fogliatto L, Paz A, Astigarraga C, Bittencourt RI, Fischer G, Daudt L. Silla LM, et al. Among authors: bittencourt ri. PLoS One. 2013 Jul 29;8(7):e68805. doi: 10.1371/journal.pone.0068805. Print 2013. PLoS One. 2013. PMID: 23922664 Free PMC article.
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C, Rimashevskaya E, Pika T, Gaidano G, Weisel K, Goranova-Marinova V, Schwarer A, Minuk L, Masszi T, Karamanesht I, Offidani M, Hungria V, Spencer A, Orlowski RZ, Gillenwater HH, Mohamed N, Feng S, Chng WJ; ENDEAVOR Investigators. Dimopoulos MA, et al. Lancet Oncol. 2016 Jan;17(1):27-38. doi: 10.1016/S1470-2045(15)00464-7. Epub 2015 Dec 5. Lancet Oncol. 2016. PMID: 26671818 Free article. Clinical Trial.
Observational study of multiple myeloma in Latin America.
Hungria VT, Maiolino A, Martinez G, Duarte GO, Bittencourt R, Peters L, Colleoni G, Oliveira LC, Crusoé E, Coelho ÉO, Pasquini R, Magalhães SM, Nunes R, Neto JV, Faria RM, Souza M, Hamerschlak N, Flantl D, Navarro JR, Conte G, Gomez-Almaguer D, Ruiz-Argüelles G, Durie BG; International Myeloma Working Group Latin America. Hungria VT, et al. Ann Hematol. 2017 Jan;96(1):65-72. doi: 10.1007/s00277-016-2866-9. Epub 2016 Nov 5. Ann Hematol. 2017. PMID: 27815724
42 results